The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Andrographis Paniculata Tablets Market Research Report 2025
Synopsis
The global Andrographis Paniculata Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Andrographis Paniculata Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Andrographis Paniculata Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Andrographis Paniculata Tablets include Shandong Hongjitang Pharmaceutical Group Co., Ltd., Jiuzhaigou Natural Pharmaceutical Co., Ltd., Guangxi Strategic Pharmaceutical Group Co., Ltd., Langzhi Group Wanrong Pharmaceutical Co., Ltd., Tiansheng Pharmaceutical Group Co., Ltd., Baoding Traditional Chinese Medicine Pharmaceutical Co., Ltd., Guangxi Jinsangzi Pharmaceutical Co., Ltd., Guangdong Jiaying Pharmaceutical Co., Ltd., Jilin Overseas Chinese Pharmaceutical Group Co., Ltd., Dong'e Ejiao Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Andrographis Paniculata Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Andrographis Paniculata Tablets.
The Andrographis Paniculata Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Andrographis Paniculata Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Andrographis Paniculata Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Shandong Hongjitang Pharmaceutical Group Co., Ltd.
Jiuzhaigou Natural Pharmaceutical Co., Ltd.
Guangxi Strategic Pharmaceutical Group Co., Ltd.
Langzhi Group Wanrong Pharmaceutical Co., Ltd.
Tiansheng Pharmaceutical Group Co., Ltd.
Baoding Traditional Chinese Medicine Pharmaceutical Co., Ltd.
Guangxi Jinsangzi Pharmaceutical Co., Ltd.
Guangdong Jiaying Pharmaceutical Co., Ltd.
Jilin Overseas Chinese Pharmaceutical Group Co., Ltd.
Dong'e Ejiao Co., Ltd.
Sichuan Tongrentai Pharmaceutical Co., Ltd.
Guangxi Dahaiguang Pharmaceutical Co., Ltd.
Hefei Cube Pharmaceutical Co., Ltd.
Sinopharm China United Pharmaceutical Co., Ltd.
Hongtaokai Pharmaceutical Co., Ltd.
Guangxi Tainuo Pharmaceutical Co., Ltd.
Sichuan Jishengtang Pharmaceutical Co., Ltd.
Henan Tiandi Pharmaceutical Co., Ltd.
Shaanxi Panlong Pharmaceutical Group Co., Ltd.
Taiji Group Zhejiang Oriental Pharmaceutical Co., Ltd.
Sichuan Everbright Pharmaceutical Co., Ltd.
Jilin Yizheng Pharmaceutical Group Co., Ltd.
Segment by Type
Each Tablet Contains 0.210g of Andrographis Paniculata Dry Extract
Each Tablet Contains 0.105g of Andrographis Paniculata Dry Extract
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Andrographis Paniculata Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Andrographis Paniculata Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Andrographis Paniculata Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Andrographis Paniculata Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Andrographis Paniculata Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Andrographis Paniculata Tablets include Shandong Hongjitang Pharmaceutical Group Co., Ltd., Jiuzhaigou Natural Pharmaceutical Co., Ltd., Guangxi Strategic Pharmaceutical Group Co., Ltd., Langzhi Group Wanrong Pharmaceutical Co., Ltd., Tiansheng Pharmaceutical Group Co., Ltd., Baoding Traditional Chinese Medicine Pharmaceutical Co., Ltd., Guangxi Jinsangzi Pharmaceutical Co., Ltd., Guangdong Jiaying Pharmaceutical Co., Ltd., Jilin Overseas Chinese Pharmaceutical Group Co., Ltd., Dong'e Ejiao Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Andrographis Paniculata Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Andrographis Paniculata Tablets.
The Andrographis Paniculata Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Andrographis Paniculata Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Andrographis Paniculata Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Shandong Hongjitang Pharmaceutical Group Co., Ltd.
Jiuzhaigou Natural Pharmaceutical Co., Ltd.
Guangxi Strategic Pharmaceutical Group Co., Ltd.
Langzhi Group Wanrong Pharmaceutical Co., Ltd.
Tiansheng Pharmaceutical Group Co., Ltd.
Baoding Traditional Chinese Medicine Pharmaceutical Co., Ltd.
Guangxi Jinsangzi Pharmaceutical Co., Ltd.
Guangdong Jiaying Pharmaceutical Co., Ltd.
Jilin Overseas Chinese Pharmaceutical Group Co., Ltd.
Dong'e Ejiao Co., Ltd.
Sichuan Tongrentai Pharmaceutical Co., Ltd.
Guangxi Dahaiguang Pharmaceutical Co., Ltd.
Hefei Cube Pharmaceutical Co., Ltd.
Sinopharm China United Pharmaceutical Co., Ltd.
Hongtaokai Pharmaceutical Co., Ltd.
Guangxi Tainuo Pharmaceutical Co., Ltd.
Sichuan Jishengtang Pharmaceutical Co., Ltd.
Henan Tiandi Pharmaceutical Co., Ltd.
Shaanxi Panlong Pharmaceutical Group Co., Ltd.
Taiji Group Zhejiang Oriental Pharmaceutical Co., Ltd.
Sichuan Everbright Pharmaceutical Co., Ltd.
Jilin Yizheng Pharmaceutical Group Co., Ltd.
Segment by Type
Each Tablet Contains 0.210g of Andrographis Paniculata Dry Extract
Each Tablet Contains 0.105g of Andrographis Paniculata Dry Extract
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Andrographis Paniculata Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Andrographis Paniculata Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Andrographis Paniculata Tablets Market Overview
1.1 Product Definition
1.2 Andrographis Paniculata Tablets by Type
1.2.1 Global Andrographis Paniculata Tablets Market Value Comparison by Type (2024-2030)
1.2.2 Each Tablet Contains 0.210g of Andrographis Paniculata Dry Extract
1.2.3 Each Tablet Contains 0.105g of Andrographis Paniculata Dry Extract
1.3 Andrographis Paniculata Tablets by Application
1.3.1 Global Andrographis Paniculata Tablets Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Andrographis Paniculata Tablets Market Size Estimates and Forecasts
1.4.1 Global Andrographis Paniculata Tablets Revenue 2019-2030
1.4.2 Global Andrographis Paniculata Tablets Sales 2019-2030
1.4.3 Global Andrographis Paniculata Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Andrographis Paniculata Tablets Market Competition by Manufacturers
2.1 Global Andrographis Paniculata Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Andrographis Paniculata Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Andrographis Paniculata Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Andrographis Paniculata Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Andrographis Paniculata Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Andrographis Paniculata Tablets, Product Type & Application
2.7 Global Key Manufacturers of Andrographis Paniculata Tablets, Date of Enter into This Industry
2.8 Global Andrographis Paniculata Tablets Market Competitive Situation and Trends
2.8.1 Global Andrographis Paniculata Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Andrographis Paniculata Tablets Players Market Share by Revenue
2.8.3 Global Andrographis Paniculata Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Andrographis Paniculata Tablets Market Scenario by Region
3.1 Global Andrographis Paniculata Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Andrographis Paniculata Tablets Sales by Region: 2019-2030
3.2.1 Global Andrographis Paniculata Tablets Sales by Region: 2019-2024
3.2.2 Global Andrographis Paniculata Tablets Sales by Region: 2025-2030
3.3 Global Andrographis Paniculata Tablets Revenue by Region: 2019-2030
3.3.1 Global Andrographis Paniculata Tablets Revenue by Region: 2019-2024
3.3.2 Global Andrographis Paniculata Tablets Revenue by Region: 2025-2030
3.4 North America Andrographis Paniculata Tablets Market Facts & Figures by Country
3.4.1 North America Andrographis Paniculata Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Andrographis Paniculata Tablets Sales by Country (2019-2030)
3.4.3 North America Andrographis Paniculata Tablets Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Andrographis Paniculata Tablets Market Facts & Figures by Country
3.5.1 Europe Andrographis Paniculata Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Andrographis Paniculata Tablets Sales by Country (2019-2030)
3.5.3 Europe Andrographis Paniculata Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Andrographis Paniculata Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Andrographis Paniculata Tablets Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Andrographis Paniculata Tablets Sales by Region (2019-2030)
3.6.3 Asia Pacific Andrographis Paniculata Tablets Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Andrographis Paniculata Tablets Market Facts & Figures by Country
3.7.1 Latin America Andrographis Paniculata Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Andrographis Paniculata Tablets Sales by Country (2019-2030)
3.7.3 Latin America Andrographis Paniculata Tablets Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Andrographis Paniculata Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Andrographis Paniculata Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Andrographis Paniculata Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Andrographis Paniculata Tablets Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Andrographis Paniculata Tablets Sales by Type (2019-2030)
4.1.1 Global Andrographis Paniculata Tablets Sales by Type (2019-2024)
4.1.2 Global Andrographis Paniculata Tablets Sales by Type (2025-2030)
4.1.3 Global Andrographis Paniculata Tablets Sales Market Share by Type (2019-2030)
4.2 Global Andrographis Paniculata Tablets Revenue by Type (2019-2030)
4.2.1 Global Andrographis Paniculata Tablets Revenue by Type (2019-2024)
4.2.2 Global Andrographis Paniculata Tablets Revenue by Type (2025-2030)
4.2.3 Global Andrographis Paniculata Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Andrographis Paniculata Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Andrographis Paniculata Tablets Sales by Application (2019-2030)
5.1.1 Global Andrographis Paniculata Tablets Sales by Application (2019-2024)
5.1.2 Global Andrographis Paniculata Tablets Sales by Application (2025-2030)
5.1.3 Global Andrographis Paniculata Tablets Sales Market Share by Application (2019-2030)
5.2 Global Andrographis Paniculata Tablets Revenue by Application (2019-2030)
5.2.1 Global Andrographis Paniculata Tablets Revenue by Application (2019-2024)
5.2.2 Global Andrographis Paniculata Tablets Revenue by Application (2025-2030)
5.2.3 Global Andrographis Paniculata Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Andrographis Paniculata Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Shandong Hongjitang Pharmaceutical Group Co., Ltd.
6.1.1 Shandong Hongjitang Pharmaceutical Group Co., Ltd. Company Information
6.1.2 Shandong Hongjitang Pharmaceutical Group Co., Ltd. Description and Business Overview
6.1.3 Shandong Hongjitang Pharmaceutical Group Co., Ltd. Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Shandong Hongjitang Pharmaceutical Group Co., Ltd. Andrographis Paniculata Tablets Product Portfolio
6.1.5 Shandong Hongjitang Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.2 Jiuzhaigou Natural Pharmaceutical Co., Ltd.
6.2.1 Jiuzhaigou Natural Pharmaceutical Co., Ltd. Company Information
6.2.2 Jiuzhaigou Natural Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Jiuzhaigou Natural Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Jiuzhaigou Natural Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product Portfolio
6.2.5 Jiuzhaigou Natural Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Guangxi Strategic Pharmaceutical Group Co., Ltd.
6.3.1 Guangxi Strategic Pharmaceutical Group Co., Ltd. Company Information
6.3.2 Guangxi Strategic Pharmaceutical Group Co., Ltd. Description and Business Overview
6.3.3 Guangxi Strategic Pharmaceutical Group Co., Ltd. Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Guangxi Strategic Pharmaceutical Group Co., Ltd. Andrographis Paniculata Tablets Product Portfolio
6.3.5 Guangxi Strategic Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.4 Langzhi Group Wanrong Pharmaceutical Co., Ltd.
6.4.1 Langzhi Group Wanrong Pharmaceutical Co., Ltd. Company Information
6.4.2 Langzhi Group Wanrong Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Langzhi Group Wanrong Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Langzhi Group Wanrong Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product Portfolio
6.4.5 Langzhi Group Wanrong Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Tiansheng Pharmaceutical Group Co., Ltd.
6.5.1 Tiansheng Pharmaceutical Group Co., Ltd. Company Information
6.5.2 Tiansheng Pharmaceutical Group Co., Ltd. Description and Business Overview
6.5.3 Tiansheng Pharmaceutical Group Co., Ltd. Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Tiansheng Pharmaceutical Group Co., Ltd. Andrographis Paniculata Tablets Product Portfolio
6.5.5 Tiansheng Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.6 Baoding Traditional Chinese Medicine Pharmaceutical Co., Ltd.
6.6.1 Baoding Traditional Chinese Medicine Pharmaceutical Co., Ltd. Company Information
6.6.2 Baoding Traditional Chinese Medicine Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Baoding Traditional Chinese Medicine Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Baoding Traditional Chinese Medicine Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product Portfolio
6.6.5 Baoding Traditional Chinese Medicine Pharmaceutical Co., Ltd. Recent Developments/Updates
6.7 Guangxi Jinsangzi Pharmaceutical Co., Ltd.
6.7.1 Guangxi Jinsangzi Pharmaceutical Co., Ltd. Company Information
6.7.2 Guangxi Jinsangzi Pharmaceutical Co., Ltd. Description and Business Overview
6.7.3 Guangxi Jinsangzi Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Guangxi Jinsangzi Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product Portfolio
6.7.5 Guangxi Jinsangzi Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Guangdong Jiaying Pharmaceutical Co., Ltd.
6.8.1 Guangdong Jiaying Pharmaceutical Co., Ltd. Company Information
6.8.2 Guangdong Jiaying Pharmaceutical Co., Ltd. Description and Business Overview
6.8.3 Guangdong Jiaying Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Guangdong Jiaying Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product Portfolio
6.8.5 Guangdong Jiaying Pharmaceutical Co., Ltd. Recent Developments/Updates
6.9 Jilin Overseas Chinese Pharmaceutical Group Co., Ltd.
6.9.1 Jilin Overseas Chinese Pharmaceutical Group Co., Ltd. Company Information
6.9.2 Jilin Overseas Chinese Pharmaceutical Group Co., Ltd. Description and Business Overview
6.9.3 Jilin Overseas Chinese Pharmaceutical Group Co., Ltd. Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Jilin Overseas Chinese Pharmaceutical Group Co., Ltd. Andrographis Paniculata Tablets Product Portfolio
6.9.5 Jilin Overseas Chinese Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.10 Dong'e Ejiao Co., Ltd.
6.10.1 Dong'e Ejiao Co., Ltd. Company Information
6.10.2 Dong'e Ejiao Co., Ltd. Description and Business Overview
6.10.3 Dong'e Ejiao Co., Ltd. Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Dong'e Ejiao Co., Ltd. Andrographis Paniculata Tablets Product Portfolio
6.10.5 Dong'e Ejiao Co., Ltd. Recent Developments/Updates
6.11 Sichuan Tongrentai Pharmaceutical Co., Ltd.
6.11.1 Sichuan Tongrentai Pharmaceutical Co., Ltd. Company Information
6.11.2 Sichuan Tongrentai Pharmaceutical Co., Ltd. Description and Business Overview
6.11.3 Sichuan Tongrentai Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sichuan Tongrentai Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product Portfolio
6.11.5 Sichuan Tongrentai Pharmaceutical Co., Ltd. Recent Developments/Updates
6.12 Guangxi Dahaiguang Pharmaceutical Co., Ltd.
6.12.1 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Company Information
6.12.2 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Description and Business Overview
6.12.3 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product Portfolio
6.12.5 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.13 Hefei Cube Pharmaceutical Co., Ltd.
6.13.1 Hefei Cube Pharmaceutical Co., Ltd. Company Information
6.13.2 Hefei Cube Pharmaceutical Co., Ltd. Description and Business Overview
6.13.3 Hefei Cube Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hefei Cube Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product Portfolio
6.13.5 Hefei Cube Pharmaceutical Co., Ltd. Recent Developments/Updates
6.14 Sinopharm China United Pharmaceutical Co., Ltd.
6.14.1 Sinopharm China United Pharmaceutical Co., Ltd. Company Information
6.14.2 Sinopharm China United Pharmaceutical Co., Ltd. Description and Business Overview
6.14.3 Sinopharm China United Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Sinopharm China United Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product Portfolio
6.14.5 Sinopharm China United Pharmaceutical Co., Ltd. Recent Developments/Updates
6.15 Hongtaokai Pharmaceutical Co., Ltd.
6.15.1 Hongtaokai Pharmaceutical Co., Ltd. Company Information
6.15.2 Hongtaokai Pharmaceutical Co., Ltd. Description and Business Overview
6.15.3 Hongtaokai Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Hongtaokai Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product Portfolio
6.15.5 Hongtaokai Pharmaceutical Co., Ltd. Recent Developments/Updates
6.16 Guangxi Tainuo Pharmaceutical Co., Ltd.
6.16.1 Guangxi Tainuo Pharmaceutical Co., Ltd. Company Information
6.16.2 Guangxi Tainuo Pharmaceutical Co., Ltd. Description and Business Overview
6.16.3 Guangxi Tainuo Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Guangxi Tainuo Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product Portfolio
6.16.5 Guangxi Tainuo Pharmaceutical Co., Ltd. Recent Developments/Updates
6.17 Sichuan Jishengtang Pharmaceutical Co., Ltd.
6.17.1 Sichuan Jishengtang Pharmaceutical Co., Ltd. Company Information
6.17.2 Sichuan Jishengtang Pharmaceutical Co., Ltd. Description and Business Overview
6.17.3 Sichuan Jishengtang Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Sichuan Jishengtang Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product Portfolio
6.17.5 Sichuan Jishengtang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.18 Henan Tiandi Pharmaceutical Co., Ltd.
6.18.1 Henan Tiandi Pharmaceutical Co., Ltd. Company Information
6.18.2 Henan Tiandi Pharmaceutical Co., Ltd. Description and Business Overview
6.18.3 Henan Tiandi Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Henan Tiandi Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product Portfolio
6.18.5 Henan Tiandi Pharmaceutical Co., Ltd. Recent Developments/Updates
6.19 Shaanxi Panlong Pharmaceutical Group Co., Ltd.
6.19.1 Shaanxi Panlong Pharmaceutical Group Co., Ltd. Company Information
6.19.2 Shaanxi Panlong Pharmaceutical Group Co., Ltd. Description and Business Overview
6.19.3 Shaanxi Panlong Pharmaceutical Group Co., Ltd. Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Shaanxi Panlong Pharmaceutical Group Co., Ltd. Andrographis Paniculata Tablets Product Portfolio
6.19.5 Shaanxi Panlong Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.20 Taiji Group Zhejiang Oriental Pharmaceutical Co., Ltd.
6.20.1 Taiji Group Zhejiang Oriental Pharmaceutical Co., Ltd. Company Information
6.20.2 Taiji Group Zhejiang Oriental Pharmaceutical Co., Ltd. Description and Business Overview
6.20.3 Taiji Group Zhejiang Oriental Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Taiji Group Zhejiang Oriental Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product Portfolio
6.20.5 Taiji Group Zhejiang Oriental Pharmaceutical Co., Ltd. Recent Developments/Updates
6.21 Sichuan Everbright Pharmaceutical Co., Ltd.
6.21.1 Sichuan Everbright Pharmaceutical Co., Ltd. Company Information
6.21.2 Sichuan Everbright Pharmaceutical Co., Ltd. Description and Business Overview
6.21.3 Sichuan Everbright Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Sichuan Everbright Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product Portfolio
6.21.5 Sichuan Everbright Pharmaceutical Co., Ltd. Recent Developments/Updates
6.22 Jilin Yizheng Pharmaceutical Group Co., Ltd.
6.22.1 Jilin Yizheng Pharmaceutical Group Co., Ltd. Company Information
6.22.2 Jilin Yizheng Pharmaceutical Group Co., Ltd. Description and Business Overview
6.22.3 Jilin Yizheng Pharmaceutical Group Co., Ltd. Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Jilin Yizheng Pharmaceutical Group Co., Ltd. Andrographis Paniculata Tablets Product Portfolio
6.22.5 Jilin Yizheng Pharmaceutical Group Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Andrographis Paniculata Tablets Industry Chain Analysis
7.2 Andrographis Paniculata Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Andrographis Paniculata Tablets Production Mode & Process
7.4 Andrographis Paniculata Tablets Sales and Marketing
7.4.1 Andrographis Paniculata Tablets Sales Channels
7.4.2 Andrographis Paniculata Tablets Distributors
7.5 Andrographis Paniculata Tablets Customers
8 Andrographis Paniculata Tablets Market Dynamics
8.1 Andrographis Paniculata Tablets Industry Trends
8.2 Andrographis Paniculata Tablets Market Drivers
8.3 Andrographis Paniculata Tablets Market Challenges
8.4 Andrographis Paniculata Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Andrographis Paniculata Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Andrographis Paniculata Tablets Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Andrographis Paniculata Tablets Market Competitive Situation by Manufacturers in 2023
Table 4. Global Andrographis Paniculata Tablets Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Andrographis Paniculata Tablets Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Andrographis Paniculata Tablets Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Andrographis Paniculata Tablets Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Andrographis Paniculata Tablets Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Andrographis Paniculata Tablets, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Andrographis Paniculata Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Andrographis Paniculata Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Andrographis Paniculata Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Andrographis Paniculata Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Andrographis Paniculata Tablets as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Andrographis Paniculata Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Andrographis Paniculata Tablets Sales by Region (2019-2024) & (K Units)
Table 18. Global Andrographis Paniculata Tablets Sales Market Share by Region (2019-2024)
Table 19. Global Andrographis Paniculata Tablets Sales by Region (2025-2030) & (K Units)
Table 20. Global Andrographis Paniculata Tablets Sales Market Share by Region (2025-2030)
Table 21. Global Andrographis Paniculata Tablets Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Andrographis Paniculata Tablets Revenue Market Share by Region (2019-2024)
Table 23. Global Andrographis Paniculata Tablets Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Andrographis Paniculata Tablets Revenue Market Share by Region (2025-2030)
Table 25. North America Andrographis Paniculata Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Andrographis Paniculata Tablets Sales by Country (2019-2024) & (K Units)
Table 27. North America Andrographis Paniculata Tablets Sales by Country (2025-2030) & (K Units)
Table 28. North America Andrographis Paniculata Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Andrographis Paniculata Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Andrographis Paniculata Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Andrographis Paniculata Tablets Sales by Country (2019-2024) & (K Units)
Table 32. Europe Andrographis Paniculata Tablets Sales by Country (2025-2030) & (K Units)
Table 33. Europe Andrographis Paniculata Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Andrographis Paniculata Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Andrographis Paniculata Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Andrographis Paniculata Tablets Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Andrographis Paniculata Tablets Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Andrographis Paniculata Tablets Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Andrographis Paniculata Tablets Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Andrographis Paniculata Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Andrographis Paniculata Tablets Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Andrographis Paniculata Tablets Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Andrographis Paniculata Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Andrographis Paniculata Tablets Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Andrographis Paniculata Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Andrographis Paniculata Tablets Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Andrographis Paniculata Tablets Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Andrographis Paniculata Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Andrographis Paniculata Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Andrographis Paniculata Tablets Sales (K Units) by Type (2019-2024)
Table 51. Global Andrographis Paniculata Tablets Sales (K Units) by Type (2025-2030)
Table 52. Global Andrographis Paniculata Tablets Sales Market Share by Type (2019-2024)
Table 53. Global Andrographis Paniculata Tablets Sales Market Share by Type (2025-2030)
Table 54. Global Andrographis Paniculata Tablets Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Andrographis Paniculata Tablets Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Andrographis Paniculata Tablets Revenue Market Share by Type (2019-2024)
Table 57. Global Andrographis Paniculata Tablets Revenue Market Share by Type (2025-2030)
Table 58. Global Andrographis Paniculata Tablets Price (US$/Unit) by Type (2019-2024)
Table 59. Global Andrographis Paniculata Tablets Price (US$/Unit) by Type (2025-2030)
Table 60. Global Andrographis Paniculata Tablets Sales (K Units) by Application (2019-2024)
Table 61. Global Andrographis Paniculata Tablets Sales (K Units) by Application (2025-2030)
Table 62. Global Andrographis Paniculata Tablets Sales Market Share by Application (2019-2024)
Table 63. Global Andrographis Paniculata Tablets Sales Market Share by Application (2025-2030)
Table 64. Global Andrographis Paniculata Tablets Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Andrographis Paniculata Tablets Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Andrographis Paniculata Tablets Revenue Market Share by Application (2019-2024)
Table 67. Global Andrographis Paniculata Tablets Revenue Market Share by Application (2025-2030)
Table 68. Global Andrographis Paniculata Tablets Price (US$/Unit) by Application (2019-2024)
Table 69. Global Andrographis Paniculata Tablets Price (US$/Unit) by Application (2025-2030)
Table 70. Shandong Hongjitang Pharmaceutical Group Co., Ltd. Company Information
Table 71. Shandong Hongjitang Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 72. Shandong Hongjitang Pharmaceutical Group Co., Ltd. Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Shandong Hongjitang Pharmaceutical Group Co., Ltd. Andrographis Paniculata Tablets Product
Table 74. Shandong Hongjitang Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 75. Jiuzhaigou Natural Pharmaceutical Co., Ltd. Company Information
Table 76. Jiuzhaigou Natural Pharmaceutical Co., Ltd. Description and Business Overview
Table 77. Jiuzhaigou Natural Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Jiuzhaigou Natural Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product
Table 79. Jiuzhaigou Natural Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 80. Guangxi Strategic Pharmaceutical Group Co., Ltd. Company Information
Table 81. Guangxi Strategic Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 82. Guangxi Strategic Pharmaceutical Group Co., Ltd. Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Guangxi Strategic Pharmaceutical Group Co., Ltd. Andrographis Paniculata Tablets Product
Table 84. Guangxi Strategic Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 85. Langzhi Group Wanrong Pharmaceutical Co., Ltd. Company Information
Table 86. Langzhi Group Wanrong Pharmaceutical Co., Ltd. Description and Business Overview
Table 87. Langzhi Group Wanrong Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Langzhi Group Wanrong Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product
Table 89. Langzhi Group Wanrong Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 90. Tiansheng Pharmaceutical Group Co., Ltd. Company Information
Table 91. Tiansheng Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 92. Tiansheng Pharmaceutical Group Co., Ltd. Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Tiansheng Pharmaceutical Group Co., Ltd. Andrographis Paniculata Tablets Product
Table 94. Tiansheng Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 95. Baoding Traditional Chinese Medicine Pharmaceutical Co., Ltd. Company Information
Table 96. Baoding Traditional Chinese Medicine Pharmaceutical Co., Ltd. Description and Business Overview
Table 97. Baoding Traditional Chinese Medicine Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Baoding Traditional Chinese Medicine Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product
Table 99. Baoding Traditional Chinese Medicine Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 100. Guangxi Jinsangzi Pharmaceutical Co., Ltd. Company Information
Table 101. Guangxi Jinsangzi Pharmaceutical Co., Ltd. Description and Business Overview
Table 102. Guangxi Jinsangzi Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Guangxi Jinsangzi Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product
Table 104. Guangxi Jinsangzi Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 105. Guangdong Jiaying Pharmaceutical Co., Ltd. Company Information
Table 106. Guangdong Jiaying Pharmaceutical Co., Ltd. Description and Business Overview
Table 107. Guangdong Jiaying Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Guangdong Jiaying Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product
Table 109. Guangdong Jiaying Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 110. Jilin Overseas Chinese Pharmaceutical Group Co., Ltd. Company Information
Table 111. Jilin Overseas Chinese Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 112. Jilin Overseas Chinese Pharmaceutical Group Co., Ltd. Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Jilin Overseas Chinese Pharmaceutical Group Co., Ltd. Andrographis Paniculata Tablets Product
Table 114. Jilin Overseas Chinese Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 115. Dong'e Ejiao Co., Ltd. Company Information
Table 116. Dong'e Ejiao Co., Ltd. Description and Business Overview
Table 117. Dong'e Ejiao Co., Ltd. Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Dong'e Ejiao Co., Ltd. Andrographis Paniculata Tablets Product
Table 119. Dong'e Ejiao Co., Ltd. Recent Developments/Updates
Table 120. Sichuan Tongrentai Pharmaceutical Co., Ltd. Company Information
Table 121. Sichuan Tongrentai Pharmaceutical Co., Ltd. Description and Business Overview
Table 122. Sichuan Tongrentai Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Sichuan Tongrentai Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product
Table 124. Sichuan Tongrentai Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 125. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Company Information
Table 126. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Description and Business Overview
Table 127. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product
Table 129. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 130. Hefei Cube Pharmaceutical Co., Ltd. Company Information
Table 131. Hefei Cube Pharmaceutical Co., Ltd. Description and Business Overview
Table 132. Hefei Cube Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Hefei Cube Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product
Table 134. Hefei Cube Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 135. Sinopharm China United Pharmaceutical Co., Ltd. Company Information
Table 136. Sinopharm China United Pharmaceutical Co., Ltd. Description and Business Overview
Table 137. Sinopharm China United Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Sinopharm China United Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product
Table 139. Sinopharm China United Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 140. Hongtaokai Pharmaceutical Co., Ltd. Company Information
Table 141. Hongtaokai Pharmaceutical Co., Ltd. Description and Business Overview
Table 142. Hongtaokai Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Hongtaokai Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product
Table 144. Hongtaokai Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 145. Guangxi Tainuo Pharmaceutical Co., Ltd. Company Information
Table 146. Guangxi Tainuo Pharmaceutical Co., Ltd. Description and Business Overview
Table 147. Guangxi Tainuo Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Guangxi Tainuo Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product
Table 149. Guangxi Tainuo Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 150. Sichuan Jishengtang Pharmaceutical Co., Ltd. Company Information
Table 151. Sichuan Jishengtang Pharmaceutical Co., Ltd. Description and Business Overview
Table 152. Sichuan Jishengtang Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Sichuan Jishengtang Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product
Table 154. Sichuan Jishengtang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 155. Henan Tiandi Pharmaceutical Co., Ltd. Company Information
Table 156. Henan Tiandi Pharmaceutical Co., Ltd. Description and Business Overview
Table 157. Henan Tiandi Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Henan Tiandi Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product
Table 159. Henan Tiandi Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 160. Shaanxi Panlong Pharmaceutical Group Co., Ltd. Company Information
Table 161. Shaanxi Panlong Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 162. Shaanxi Panlong Pharmaceutical Group Co., Ltd. Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Shaanxi Panlong Pharmaceutical Group Co., Ltd. Andrographis Paniculata Tablets Product
Table 164. Shaanxi Panlong Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 165. Taiji Group Zhejiang Oriental Pharmaceutical Co., Ltd. Company Information
Table 166. Taiji Group Zhejiang Oriental Pharmaceutical Co., Ltd. Description and Business Overview
Table 167. Taiji Group Zhejiang Oriental Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. Taiji Group Zhejiang Oriental Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product
Table 169. Taiji Group Zhejiang Oriental Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 170. Sichuan Everbright Pharmaceutical Co., Ltd. Company Information
Table 171. Sichuan Everbright Pharmaceutical Co., Ltd. Description and Business Overview
Table 172. Sichuan Everbright Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 173. Sichuan Everbright Pharmaceutical Co., Ltd. Andrographis Paniculata Tablets Product
Table 174. Sichuan Everbright Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 175. Jilin Yizheng Pharmaceutical Group Co., Ltd. Company Information
Table 176. Jilin Yizheng Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 177. Jilin Yizheng Pharmaceutical Group Co., Ltd. Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 178. Jilin Yizheng Pharmaceutical Group Co., Ltd. Andrographis Paniculata Tablets Product
Table 179. Jilin Yizheng Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Andrographis Paniculata Tablets Distributors List
Table 183. Andrographis Paniculata Tablets Customers List
Table 184. Andrographis Paniculata Tablets Market Trends
Table 185. Andrographis Paniculata Tablets Market Drivers
Table 186. Andrographis Paniculata Tablets Market Challenges
Table 187. Andrographis Paniculata Tablets Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
Table 191. Authors List of This Report
List of Figures
Figure 1. Product Picture of Andrographis Paniculata Tablets
Figure 2. Global Andrographis Paniculata Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Andrographis Paniculata Tablets Market Share by Type: 2023 & 2030
Figure 4. Each Tablet Contains 0.210g of Andrographis Paniculata Dry Extract Product Picture
Figure 5. Each Tablet Contains 0.105g of Andrographis Paniculata Dry Extract Product Picture
Figure 6. Global Andrographis Paniculata Tablets Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Andrographis Paniculata Tablets Market Share by Application: 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Andrographis Paniculata Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Andrographis Paniculata Tablets Market Size (2019-2030) & (US$ Million)
Figure 13. Global Andrographis Paniculata Tablets Sales (2019-2030) & (K Units)
Figure 14. Global Andrographis Paniculata Tablets Average Price (US$/Unit) & (2019-2030)
Figure 15. Andrographis Paniculata Tablets Report Years Considered
Figure 16. Andrographis Paniculata Tablets Sales Share by Manufacturers in 2023
Figure 17. Global Andrographis Paniculata Tablets Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Andrographis Paniculata Tablets Players: Market Share by Revenue in Andrographis Paniculata Tablets in 2023
Figure 19. Andrographis Paniculata Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Andrographis Paniculata Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Andrographis Paniculata Tablets Sales Market Share by Country (2019-2030)
Figure 22. North America Andrographis Paniculata Tablets Revenue Market Share by Country (2019-2030)
Figure 23. United States Andrographis Paniculata Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Andrographis Paniculata Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Andrographis Paniculata Tablets Sales Market Share by Country (2019-2030)
Figure 26. Europe Andrographis Paniculata Tablets Revenue Market Share by Country (2019-2030)
Figure 27. Germany Andrographis Paniculata Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Andrographis Paniculata Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Andrographis Paniculata Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Andrographis Paniculata Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Andrographis Paniculata Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Andrographis Paniculata Tablets Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Andrographis Paniculata Tablets Revenue Market Share by Region (2019-2030)
Figure 34. China Andrographis Paniculata Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Andrographis Paniculata Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Andrographis Paniculata Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Andrographis Paniculata Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Andrographis Paniculata Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Andrographis Paniculata Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Andrographis Paniculata Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Andrographis Paniculata Tablets Sales Market Share by Country (2019-2030)
Figure 42. Mexico Andrographis Paniculata Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Andrographis Paniculata Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Andrographis Paniculata Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Andrographis Paniculata Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Andrographis Paniculata Tablets Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Andrographis Paniculata Tablets Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Andrographis Paniculata Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Andrographis Paniculata Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Andrographis Paniculata Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Andrographis Paniculata Tablets by Type (2019-2030)
Figure 52. Global Revenue Market Share of Andrographis Paniculata Tablets by Type (2019-2030)
Figure 53. Global Andrographis Paniculata Tablets Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Andrographis Paniculata Tablets by Application (2019-2030)
Figure 55. Global Revenue Market Share of Andrographis Paniculata Tablets by Application (2019-2030)
Figure 56. Global Andrographis Paniculata Tablets Price (US$/Unit) by Application (2019-2030)
Figure 57. Andrographis Paniculata Tablets Value Chain
Figure 58. Andrographis Paniculata Tablets Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
